Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s stock price shot up 12.5% on Monday . The company traded as high as $2.45 and last traded at $2.25. 3,777 shares changed hands during trading, an increase of 164% from the average session volume of 1,433 shares. The stock had previously closed at $2.00.
Silence Therapeutics Price Performance
The firm’s fifty day simple moving average is $4.33 and its 200-day simple moving average is $5.84.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Read More
- Five stocks we like better than Silence Therapeutics
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- How to Use the MarketBeat Stock Screener
- 2 Drone Stocks Surging from Increased Media Attention
- What to Know About Investing in Penny Stocks
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
